EWTX

Edgewise Therapeutics
EWTX

Latest price

Financial Snapshot

gainify

Market Data

Market Cap
$1.56B
EV
$1.09B
Shares Outstanding
112.13M
Beta
0.33

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
$42.78
P/E 2025E
-
P/Revenue 2025E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Edgewise Therapeutics, Inc.

gainify
EWTX

Edgewise Therapeutics, Inc.

EWTX

Edgewise Therapeutics, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, EDG-5506, an orally administered small molecule that is in Phase II clinical trials, designed...

Sector

Healthcare

Industry

Biotechnology

CEO

Koch, Kevin

Employees

110

IPO Date

2021-03-26

Headquarters

1715 38th Street, Boulder, Colorado, 80301, United States

gainify
mailcontactcontact
powered-by-sp

NEWSLETTER

COMPANY

© Copyright 2025, All Rights Reserved